Web Rx drugs: "complex and emerging problem"

22 July 2007

A coroner's inquest in British Columbia, Canada, has confirmed that a 58-year old woman died of cardiac arrhythmia stemming from metal toxicity, as a result of taking fake prescription drugs bought on-line (Marketletter April 2). Among the substances found in the victim's liver was 15 times the normal level of aluminium.

As one pharmaceutical industry blogger put it: "by trying to soothe her nerves with a few easily bought pills, Marcia Bergeron became the poster child for the reimportation debate." A representative of global drug behemoth Pfizer referred to the case at a US congressional hearing, prior to the verdict, into the possibility of legalizing parallel trade in prescription drugs from Canada.

Numerous symptoms of metal poisoning

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight